Powered by

-Foamix Reports Second Quarter 2019 Financial Results and Provides Corporate Update

Aug 08, 2019 - ENP Newswire
Financial Results

REHOVOT - Foamix Pharmaceuticals Ltd. (Nasdaq: FOMX) ('Foamix' or the 'Company'), a clinical stage specialty pharmaceutical company focused on developing and commercializing proprietary topical therapies to address unmet needs in dermatology, today announced financial results for the three and six months ended June 30, 2019 and provided a corporate update.

'We continue to make excellent progress advancing our late stage pipeline in dermatology and in making preparations to become a commerc...